MedTrace Logo

Postoperative Pain Management on Patients Undergoing Lung Tumor Resection

NCT06397807 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-05-03

No results posted yet for this study

Summary

Multimodal analgesia (MMA) is an essential part of Enhanced Recovery After Surgery (ERAS) protocol. The principle of MMA is to manage pain with analgesics of multiple classes acting on distinct target sites through different strategies. MMA can reduce the adverse reaction caused by opioids and improve the quality of recovery from surgery. Inadequate postoperative pain management will increase the risk of complications, including pneumonia, deep vein thrombosis, infection, delayed surgical healing, and chronic postoperative pain.

Conditions

Interventions

DRUG

Dinalbuphine sebacate

Dinalbuphine sebacate (DS) is a long-acting injectable. With oil-based formulation, DS will slowly releases to blood vessel and be hydrolyzed to nalbuphine after intramuscularly injection. The analgesic effect lasts around 5 to 7 days.

DRUG

Analgesic injectables

Opioids, NSAIDs or acetamol will be administrated as need.

DRUG

Enteral analgesics

Opioids, NSAIDs or acetaminophen will be prescribed if necessary.

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Hsin-Yuan Fang · China Medical University Hospital

  • Po-Han Li · China Medical University Hospital

  • Kin-Shing Poon · China Medical University Hospital

  • Hsiurong Liao · China Medical University Hospital

  • Tzu-Min Huang · China Medical University Hospital

  • Yu-Cheng Shen · China Medical University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-31
Primary Completion
2026-03-02
Completion
2026-05-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06397807 on ClinicalTrials.gov